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Abstract
Background
Previous studies indicate that psychosocial factors can impact COPD prevalence. However,
research into this association has predominantly focused on negative factors such as
depression. The aim of this study was to examine whether high subjective wellbeing is asso-
ciated with a lower risk of developing COPD.
Methods
The sample consisted of 12,246 participants aged50 years from the Survey of Health,
Ageing and Retirement in Europe. We used Cox proportional hazards regression to exam-
ine the relationship between wellbeing (measured using the CASP-12) and incidence of
COPD over a follow-up period of 9 years.
Results
There was a significant association between wellbeing and COPD risk. In age-adjusted
analyses, a standard deviation increase in CASP-12 score was associated with a reduced
risk of COPD; hazard ratios (95% confidence intervals) for men and women were 0.67
(0.60–0.75) and 0.80 (0.73–0.87) respectively. After additional adjustment for demographic
and health behaviour variables, this association remained significant for men but not for
women: the fully-adjusted hazard ratios were 0.80 (0.70–0.91) and 0.91 (0.82–1.03)
respectively.
Conclusions
Greater wellbeing is associated with a reduced risk of COPD, particularly in men. Future
research is needed to establish whether gender reliably moderates this association.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide [1]. This progressive disease is characterised by persistent airflow limitation caused
by a combination of small airways disease (obstructive bronchiolitis) and emphysema [2].
Established risk factors for COPD include smoking, exposure to air pollutants, chronic lung
infections, older age and genetic factors [1]. Recent reports suggest that prevalence rates of
COPD may have stabilised in some developed countries as a result of reduced smoking preva-
lence [1]. Given this recent decline in tobacco use, Rosenberg et al. [1] suggest that future
trends in the prevalence of COPD will be driven by factors other than smoking prevalence.
In addition to traditional risk factors, there is evidence that psychosocial factors impact on
COPD prevalence. Current evidence for this association comes predominantly from studies
into negative psychosocial factors such as depression or anxiety. For instance, a longitudinal
study involving 14,682 men and women, found that major depression at baseline was associ-
ated with a significantly higher risk of developing COPD over a two year follow up period. The
effect size was not substantially changed by the inclusion of gender, age, health care use and
smoking [3]. A second study examined the association between psychological distress and risk
of COPD and found that psychological distress was associated with an increased risk over the
3 year follow up period in women (n = 2203) but not in men (n = 1682) [4].
There are a number or mechanisms that could account for the link between psychosocial
factors and COPD risk. Depression or anxiety may confer an increased risk due to associations
with traditional risk factors including higher levels of smoking and physical inactivity [4]. In
addition, negative psychosocial factors could impact COPD risk via more direct physiological
pathways. Previous studies have documented a link between depression or anxiety and elevated
levels of inflammatory markers [5,6] as well as chronic inflammation and the development
and progression of COPD [7]. Currently, research into the association between wellbeing and
COPD risk is limited. However, positive states such as high wellbeing have been linked with
health protective behaviours (including physical activity) and lower levels of inflammatory bio-
markers. Thus, high wellbeing may be associated with a reduced COPD risk.
An examination of both positive and negative factors in relation to COPD risk is warranted
as previous studies into wellbeing and health indicate that wellbeing can impact on health
independently of negative affect [8,9]. One previous study has examined the association
between subjective wellbeing (as measured by the CASP-19) and the risk of COPD (defined as
a diagnosis of chronic bronchitis or emphysema) [10]. The study sample consisted of people
aged 50 and over from the English Longitudinal Study of Ageing (ELSA). In people below the
age of 65, higher wellbeing was associated with a reduced risk of developing COPD over an 8
year follow up period. This effect remained significant after adjusting for health behaviours,
depressive symptoms, demographic variables, BMI and history of asthma. This finding indi-
cates that high wellbeing may be protective against the risk of COPD; and that this effect is in
part independent of negative emotion.
The association between wellbeing and COPD risk may have clinical relevance; if high
wellbeing confers a reduced risk of COPD, interventions that increase wellbeing may help in
reducing COPD prevalence. Previous studies have illustrated that public interventions can
effectively increase wellbeing among older adults [11–13]. However, before such an approach
can be recommended, further research is needed to confirm whether high wellbeing reliably
reduces COPD risk, and to identify potential mechanisms that underlie this association. The
aim of the current study was to address these two issues. We assessed the association between
wellbeing and COPD risk in a nationally representative European sample of community-
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dwelling individuals aged 50 years and over. This data set allowed us to control for a range of
covariates in our analysis including health behaviours and depressive symptoms.
Methods
Study population
The Survey of Health, Ageing and Retirement in Europe (SHARE) is a multi-national prospec-
tive cohort study of people aged 50 and over [14,15]. Based on probability samples, SHARE is
designed to be representative of the older community-dwelling population in 11 European
countries (Denmark, Sweden, Austria, France, Germany, Switzerland, Belgium, the Nether-
lands, Spain, Italy and Greece) and Israel. Sampling techniques varied by country (depending
on what data was available) and included simple random sampling from national population
registers, multi-stage sampling using regional/local population registers and single or multi-
stage sampling using telephone directories followed by screening in the field. People were
excluded from the study if they were born after 1954, or if they were incarcerated, hospitalized
or out of the country during the entire survey period, unable to speak the country’s language
(s) or had moved to an unknown address. Eligible individuals were recruited by telephone or
in person at their home address. Participants have been interviewed biennially since 2004.
Data from waves 1–5 (2004–2013) were used in the current analysis. SHARE has been
reviewed and approved by the Ethics Committee of the University of Mannheim [16] and all
participants provided written consent.
Wellbeing
Wellbeing at wave 1 was assessed with the CASP-12, participants respond to 12 questions on a
four point Likert scale. Scores range from 0–48 with higher scores indicating higher wellbeing.
The CASP-12 is an abridged version of the CASP-19 [17] and was developed for use in the
SHARE sample. The CASP-12 has been validated in an older Spanish community dwelling
sample and has satisfactory internal consistency [18]For the study sample, CASP-12 scores
were relatively stable over the follow up period. The test re-test correlation coefficient for
CASP-12 scores at wave 1 and wave 5 was high: r = 0.52, p =<0.001.
COPD
At each wave (excluding wave 3), participants were asked whether a doctor had ever told them
that they had “COPD such as chronic bronchitis or emphysema.” Participants that did not
report a diagnosis at wave 1 but reported a diagnosis in a subsequent wave were classified as
incident cases. Data on date of COPD diagnosis was not available, for the purposes of the anal-
ysis, the month and year of the interview at which the participant first reported a diagnosis of
COPD was used as the date of diagnosis.
Covariate variables
We chose covariates variables that have been linked with wellbeing and COPD in previous
studies. These included age, gender and height, depressive symptoms, socioeconomic status,
chronic physical conditions, health behaviours and body mass index. All previously associated
with wellbeing [19–25] and with COPD risk [1,3,26–30]. The EURO-D was used to assess
symptoms of depression [31]. The scale consists of 12 items–all of which are taken from the
Geriatric Mental State [32]. The EURO-D is internally consistent and has two factors: ‘affective
suffering’ and ‘motivation’ [31,33]. Additional variables adjusted for were SES and education.
Socioeconomic status was indexed by total household assets, gross value of home, value of any
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other real estate, value of any share of business and value of any vehicles minus mortgage of
main residence. The sample was divided into quintiles according to total household wealth.
Level of education was classified using the International Standard Classification of Education
(ISCED-97). Education categories were: pre-primary or primary, lower secondary, upper or
post-secondary and first or second stage tertiary. We adjusted for physical activity, alcohol
consumption, smoking status, pack years and BMI. Participants reported how often they
engaged in vigorous and or moderate physical activity. Response options were: ‘more than
once a week’, ‘once a week’ and ‘one to three times a month’, and ‘hardly ever or never’. As has
been done previously [34], we used these responses to create three categories: physical inactiv-
ity, moderate but not vigorous activity at least once a week and vigorous physical activity at
least once a week. Participants reported frequency of alcohol consumption, response options
were ‘almost every day’, ‘5 or 6 days a week’, ‘3 or 4 days a week’, ‘once or twice a week’, ‘once
or twice a month’, ‘less than once a month’ and ‘not at all in the last 6 months’. As previously
[34], we used these responses to create 4 categories: ‘more than once a week’, ‘once a week’,
‘one to three times a month’ and ‘hardly ever or never’. Participants reported their smoking
status (non-smoker, former smoker or current smoker). Former and current smokers reported
the number of cigarettes, cigars or pipes they smoked per day and the number of years they
had smoked. For the pack years variable, number of cigars and pipes per day were converted
to the equivalent number of cigarettes (1 cigar or pipe = 2.5 cigarettes). We then derived the
number of cigarette packs smoked per day (n of cigarettes per day/20) and multiplied the num-
ber of cigarette packs per day by the number of years smoked. The pack years variable was
coded as 0 for non-smokers. BMI (kg/m2) was derived from participant self-reported height
and weight. Participants were categorised according to World Health Organisation guidelines
as being underweight (below 18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25–
29.9 kg/m2), and obese (30 kg/m2 or above) [35]. Finally, adjustments were made for prevalent
hypertension, high cholesterol, diabetes, heart attack, stroke, cataracts, osteoporosis, arthritis
and asthma at wave 1. These chronic conditions commonly co-occur with COPD [36] and
have been associated with lower wellbeing [37,38].
Analytical sample
At wave 1, 30, 816 participants took part. Our sample included 12,246 of these participants.
Participants were excluded if they reported a diagnosis of COPD at wave 1 or did not know
whether they had been diagnosed with COPD or if they refused to respond to the question
(n = 1,664; 5%). We also excluded participants that only participated at wave 1 (n = 7,363; 25%),
had missing wellbeing data (n = 7970; 37%) or had missing covariate data (n = 1573; 11%).
Participants with missing wellbeing data were older, more likely to be female, consumed
less alcohol, were less physically active, were less likely to smoke, had fewer years of education
and were more likely to report a history or stroke, diabetes and heart attack. These participants
also had a higher depression score and had lower SES.
Statistical analysis
Proportional hazards regression was conducted to examine the association between CASP-12
scores at baseline and incidence of COPD over the follow-up period. Survival time was calcu-
lated from the date of the wave 1 interview to the date of COPD diagnosis, or the date of the
last follow up interview. The mean duration of follow up was 6 years. Preliminary analysis
(predicting COPD risk) indicated a significant interaction between gender and CASP-12 (p =
0.02). Consequently, proportional hazards regression analysis was conducted for women and
men separately.
Wellbeing and chronic lung disease incidence
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There were 8 different adjustment models, the first model adjusted for age and the subsequent
6 models adjusted for age and each covariate in turn (this approach allowed us to identify the
amount of variance explained by each covariate); the final model adjusted for age and all covari-
ates variables (height, SES, depressive symptoms, comorbidities, health behaviours and BMI).
To rule out the effect of reverse causality (i.e. undiagnosed pre-existing lung disease influ-
encing wellbeing), the regression was repeated excluding the first two years of follow up. Haz-
ard ratios (HR) and 95% confidence intervals (CI) are expressed according to a standard
deviation (SD) increase in CASP-12 score.
To test for possible bias due to missing data, multiple multivariate imputation was used to
impute values of covariates with missing values. This approach relies on the assumption that
data are missing at random—meaning that the pattern of missingness is systematic and can be
predicted by observed data [39]. We assumed data were missing at random as missingness was
significantly correlated with other measured variables [39]. Missing data were imputed for the
sample of participants that took part at wave 1, did not report a diagnosis of COPD at wave 1
and had information on incident COPD (n = 21,789). The imputation models included sur-
vival time, COPD incidence and the covariates; 35 imputed datasets were generated using
chained equations imputation.
Results
Table 1 shows the baseline characteristics of the sample (n = 12,246) according to tertiles of
wellbeing. Mean wellbeing scores for the lowest, middle and highest tertiles were 30.67
(SD = 3.92), 38.06 (SD = 1.41) and 43.48 (SD = 1.94) respectively. On average, participants
with higher wellbeing were younger, taller, wealthier, more educated, more likely to be male,
less likely to report a history of chronic disease excluding asthma and less likely to smoke.
They also had lower depressive symptom scores, lower BMI, were more physically active and
consumed more alcohol.
Table 2 displays the HRs for incident COPD for men and women according to a SD increase
in CASP-12 score. There were 715 incident cases reported between waves 2 and 5 (Table 2).
People with higher CASP-12 scores had a significantly lower risk of incident lung disease after
adjusting for age. This reduction appeared to be greater for men than for women. A SD increase
in CASP-12 score was associated with a 33% (HR: 0.67; 95% CI: 0.60–0.75) decrease in COPD
risk in men and a 20% (HR: 0.80; 95% CI: 0.73–0.87) decrease in COPD risk in women. This
association remained significant but was attenuated in men and women after adjusting for each
covariate separately. Adjusting for depressive symptoms and SES led to the highest percentages
of attenuation, 25 or 15% and 20 or 15%, respectively. Adjusting for BMI and history of relevant
chronic conditions led to a higher percentage of attenuation for women than for men.
In the model adjusted for all covariates, the association between higher wellbeing and lower
COPD risk remained significant for men (HR: 0.80; 95% CI: 0.70–0.91) but was no longer sig-
nificant for women (HR: 0.91; 95% CI: 0.82–1.03). In the fully adjusted model, factors signifi-
cantly associated with increased COPD risk included older age, being female, smoking, being
underweight, having fewer years of education, history of arthritis and history of asthma.
The observed association between CASP-12 score and COPD risk was little changed by the
exclusion of cases diagnosed in the first two years of follow-up or the exclusion of participants
that reported a history of asthma at wave 1. The pooled effect sizes from analysis with imputed
information were similar to those obtained from analysis employing the sample with complete
data–suggesting that missing covariate data did not significantly bias the results. See S1 Table
for a comparison of results.
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Discussion
This study successfully replicated the finding that wellbeing is protective against COPD risk
[10]. The association between higher CASP-12 scores remained significant following addi-
tional adjustment for covariate variables (wealth, education, height, depressive symptoms,
comorbidities, health behaviours and BMI) in men but not in women.
Adjusting for traditional risk factors attenuated the association between wellbeing and
COPD risk. SES and depressive symptoms emerged as significant covariates. This effect is
unsurprising, SES is associated with levels of wellbeing [23] and risk of COPD [27]. Depressive
Table 1. Baseline characteristics stratified according to tertiles of CASP-12 scores (lowest, middle and highest subjective wellbeing) Total
N = 12,246.
Characteristics Lowest Middle Highest p-trenda
Age (yrs), M (SD) 64.81 (10.44) 63.07 (9.77) 62.09 (8.96) <0.001
EURO-D score Mdn (IQR) 3 (1–5) 2 (1–3) 1 (0–2) <0.001
Total wealth (€) M (SD) 335,408.52
(134,8262.59)
589,167.40 (220,7638.04) 853,964.48 (261,0017.07) <0.001
Female, No. (%) 2281 (58.64) 2093 (54.05) 2379 (53.06) <0.001
BMI (kg/m2) M (SD) 26.93 (4.46) 26.36 (4.19) 25.96 (3.98) <0.001
Height (cm) 166.45 (8.93) 168.51 (8.91) 169.49 (8.84) <0.001
Physical Activity, No. (%) <0.001
Physically inactive 679 (17.46) 309 (7.98) 242 (5.40)
Moderate physical activity 1500 (38.56) 1453 (37.53) 1422 (31.71)
Vigorous physical activity 1711 (43.98) 2110 (54.49) 2820 (62.89)
Alcohol consumption, No. (%) <0.001
More than once a week 916 (23.55) 968 (25.00) 1247 (27.81)
Once a week 804 (20.67) 1156 (29.86) 1574 (35.10)
One to three times a month 811 (20.85) 879 (22.70) 870 (19.40)
Hardly ever or never 1359 (34.94) 869 (22.44) 793 (17.69)
Smoking status, No. (%) <0.001
Non-smoker 768 (19.74) 757 (19.55) 846 (18.87)
Former smoker 945 (24.29) 1140 (29.44) 1414 (31.53)
Smoker 2177 (55.96) 1975 (51.01) 2224 (49.60)
Pack Years Mdn (IQR) 25.00
(10.00–42.00)
20.00
(7.50 37.50)
18.50
(7.00–35.00)
<0.001
Education, No. (%) <0.001
Pre-primary or primary 1718 (44.16) 1067 (27.56) 829 (18.49)
Lower secondary, 716 (8.41) 696 (17.96) 844 (18.82)
Upper or post-secondary 1005 (25.84) 1269 (32.77) 1555 (34.68)
First or second stage tertiary, 451 (11.59) 840 (21.69) 1256 (28.01)
History of heart attack, No. (%) 556 (14.29) 429 (11.08) 321 (7.16) <0.001
History of high cholesterol, No. (%) 876 (22.52) 813 (20.99) 807 (17.99) <0.001
History of stroke, No. (%) 179 (4.60) 115 (2.97) 87 (1.94) <0.001
History of asthma, No. (%) 144 (3.72) 147 (3.80) 140 (3.12) 0.19
History of arthritis, No. (%) 991 (25.48) 648 (16.74) 490 (10.93) <0.001
History of osteoporosis, No. (%) 421 (10.82) 264 (6.82) 184 (4.10) <0.001
History of cataracts, No. (%) 338 (8.69) 253 (6.53) 244 (5.44) <0.001
History of diabetes, No. (%) 421 (10.82) 264 (6.82) 184 (4.10) <0.001
History of hypertension, No. (%) 338 (8.69) 253 (6.53) 244 (5.44) <0.001
a statistical significance is based χ2 tests or one-way ANOVA, as appropriate.
https://doi.org/10.1371/journal.pone.0181320.t001
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symptoms are strongly associated with lower wellbeing [19]; in the SHARE sample, there was a
significant negative correlation between the two measures (r = 0.64 p< 0.001 after adjusting
for unreliability). Depression has also previously been identified as a risk factor for COPD
[26]. Adjusting for BMI and health behaviours including alcohol consumption, smoking sta-
tus, pack years and physical activity attenuated the association between wellbeing and COPD
further. Again, this finding is as expected considering the documented association between
wellbeing and health behaviours [21] and health behaviours (smoking in particular) and risk
of COPD [1]. Health behaviours may partially mediate the association between wellbeing and
COPD risk. However, it is also possible that these factors are confounders of this risk associa-
tion; that is, health behaviours and BMI may impact on levels of wellbeing and the risk of
COPD. Longitudinal mediation analysis could help establish the role of health behaviours in
the association between wellbeing and COPD risk.
We observed a stronger association between wellbeing and COPD risk in men compared
with women. There is no clear consensus regarding gender as a modifier of effects of psychoso-
cial risk factors. It is plausible that the gender interaction observed in this study is specific to
the association between wellbeing and COPD. There are a number of possible explanations for
this effect. For instance, Watson et al. [40] suggest that women experience a more severe form
of COPD than men. It is possible that wellbeing is not potentially protective against this more
severe form of the disease. Alternatively, COPD is underdiagnosed in women as it is tradition-
ally considered a ‘male’ disease (mainly due to previously higher smoking rates among men)
[41]. It is possible that less reliable diagnosis of COPD in women resulted in an underestima-
tion of the association between wellbeing and COPD for women in this study.
For the men in the sample, established risk factors and comorbidities did not fully account
for the association between wellbeing and the risk of COPD. This suggests that additional
mechanisms may account for the association. One possibility is that wellbeing impacts directly
on physiological processes relevant to COPD risk. This causal pathway has been proposed by
Table 2. Hazard ratios (95% confidence intervals) for incident COPD in women and men according to a SD increase in CASP-12 score.
Covariates Adjusted for Gender HR (95% CI) % Attenuation
Age Women 0.80 (0.73–0.87)**
Men 0.67 (0.60–0.75)**
Age+ Wealth + Education Women 0.85 (0.77–0.93)* 25%
Men 0.72 (0.64–0.80)** 15%
Age+ Height Women 0.79 (0.72–0.87)** -5%
Men 0.69 (0.62–0.76)** 6%
Age+ EURO-D Women 0.84 (0.76–0.94)* 20%
Men 0.72 (0.64–0.82)** 15%
Age + Comorbidities Women 0.85 (0.77–0.93)* 25%
Men 0.70 (0.63–0.78)** 9%
Age+ Health Behaviours Women 0.83 (0.76–0.92)** 15%
Men 0.70 (0.64–0.79)** 9%
Age+ BMI Women 0.83 (0.75–0.91)** 15%
Men 0.68 (0.61–0.76)** 3%
All Covariates Women 0.91 (0.82–1.03) 55%
Men 0.80 (0.70–0.91)* 39%
** p <0.001
* p <0.05
https://doi.org/10.1371/journal.pone.0181320.t002
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Kubzansky et al. [42]. The development and progression of COPD is associated with an abnor-
mal inflammatory response. Wellbeing could impact this process as previous studies have doc-
umented a significant association between positive affect and biomarkers of inflammation
[43,44]. The data in SHARE did not allow for an assessment of this causal pathway. However,
further research testing whether inflammatory processes mediate the association between well-
being and COPD risk is warranted.
There are a number of additional factors (not recorded at wave 1 of SHARE) that may
underlie the association between wellbeing COPD risk. Firstly, diet quality may play a role.
Poor diet quality (high intake of processed meats, refined grains and sugar sweetened drinks)
has been identified as a risk factor for COPD [45] and has also been associated with low wellbe-
ing [21]. A further possibility is that the association between wellbeing and COPD risk is
driven by the link between wellbeing and the likelihood of reporting disease symptoms. There
is evidence that people with high positive affect report fewer and less severe disease symptoms
than people with low positive affect even when objective markers of disease are held constant
[49]. It is plausible that participants with high wellbeing were less likely to receive a formal
diagnosis as they reported fewer disease symptoms. Finally, it is also possible that wellbeing
and COPD are not causally related. For instance, work environment may act as a third variable
confound. Factory and construction work is associated with an increased risk of COPD due to
occupational exposures to vapours, gas, dust and fumes [46]. Working in a loud or noxious
environment is also associated with reduced wellbeing [47,48]. Thus, our results could, at least
in part, reflect the effect of work environment on COPD risk and levels of wellbeing. Early life
or genetic factors could also confound the association between wellbeing and COPD risk. The
development of lung function in infancy has been identified as a significant predictor of pul-
monary health in old age [50]. Risk factors for abnormal lung development include premature
birth or low birthweight, tobacco exposure during and after pregnancy and childhood respira-
tory illness [50]. Stafford et al. [51] report that childhood illness and family psychosocial fac-
tors are related to wellbeing in early old age. The contribution of genetics to the association
between wellbeing and COPD risk remains to be explored.
Strengths of the study include the sample–which was large and representative of people
age 50 living in Europe and Israel. The available data allowed for adjustment for many
covariate variables. Our study also had some limitations. Firstly, over a third of our partici-
pants (37%) were excluded due to missing wellbeing data. Participants with missing wellbeing
data differed from those included in the sample on several key variables, including depressive
symptoms and health behaviour. Excluding these participants may therefore have biased the
results; however, analysis with imputed missing covariate data yielded similar effect sizes to
those obtained for the sample with complete data suggesting that this exclusion did not result
in any bias. Secondly, diagnosis of COPD was assessed using a self-report measure—which has
been associated with some degree of reporting bias [52]. Although, others have found that self-
report measures of physician diagnosed conditions provide a valid estimate of disease preva-
lence [53]. Finally, although depressive symptoms were controlled for, it was not possible to
control for two psychosocial factors previously associated with pulmonary health: perceived
stress and hostility [54,55] as well as several established risk factors that may be related to well-
being, including diet, exposure to air pollutants and early life influences.
Our results support the idea that greater wellbeing is associated with a reduced risk of
COPD. In addition to conferring the inherent benefits of increased wellbeing [11–13], inter-
ventions designed to improve wellbeing may help in reducing the prevalence of COPD among
older adults. Additional research is needed to further delineate the causal pathways between
wellbeing and COPD risk. Factors including inflammatory processes, symptom severity or
Wellbeing and chronic lung disease incidence
PLOS ONE | https://doi.org/10.1371/journal.pone.0181320 July 20, 2017 8 / 12
symptom reporting, diet, work environment, early life exposures as well as perceived stress or
hostility in adulthood may be implicated in this association.
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